• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
IRBs and the Protection-Inclusion Dilemma: Finding a Balance.IRBs 与保护-纳入困境:寻求平衡。
Am J Bioeth. 2023 Jun;23(6):75-88. doi: 10.1080/15265161.2022.2063434. Epub 2022 Apr 28.
2
Institutional Review Board Use of Outside Experts: What Do We Know?机构审查委员会使用外部专家:我们了解多少?
Ethics Hum Res. 2022 Mar;44(2):26-32. doi: 10.1002/eahr.500121.
3
A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.一项关于美国食品药品监督管理局发给机构审查委员会警告信的研究。
Clin Invest Med. 2004 Dec;27(6):316-23.
4
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
5
Protecting the Vulnerable and Including the Under-Represented: IRB Practices and Attitudes.保护弱势群体和代表性不足的人群:IRB 的实践和态度。
J Empir Res Hum Res Ethics. 2023 Feb-Apr;18(1-2):58-68. doi: 10.1177/15562646221138450. Epub 2022 Dec 7.
6
IRB Oversight of Patient-Centered Outcomes Research: A National Survey of IRB Chairpersons.以患者为中心的结局研究的机构审查委员会监督:对机构审查委员会主席的全国性调查。
J Empir Res Hum Res Ethics. 2018 Oct;13(4):421-431. doi: 10.1177/1556264618779785. Epub 2018 Jun 14.
7
Should society allow research ethics boards to be run as for-profit enterprises?社会应该允许研究伦理委员会作为营利性企业来运作吗?
PLoS Med. 2006 Jul;3(7):e309. doi: 10.1371/journal.pmed.0030309. Epub 2006 Jul 25.
8
Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight.降落伞与参与者保护:从质量迈向推进有效的研究伦理监督
J Empir Res Hum Res Ethics. 2019 Jul;14(3):190-196. doi: 10.1177/1556264618812625. Epub 2018 Dec 12.
9
Do N-of-1 Trials Need IRB Review?单病例试验需要机构审查委员会(IRB)审查吗?
J Empir Res Hum Res Ethics. 2016 Jul;11(3):250-5. doi: 10.1177/1556264616662560.
10
US IRBs confronting research in the developing world.美国机构伦理审查委员会在发展中国家面临的研究挑战。
Dev World Bioeth. 2012 Aug;12(2):63-73. doi: 10.1111/j.1471-8847.2012.00324.x. Epub 2012 Apr 20.

引用本文的文献

1
"The hardest part of what we're doing": research staff perspectives on engaging marginalized populations in substance use trials.“我们所做之事最艰难的部分”:研究人员对让边缘化人群参与药物使用试验的看法
Subst Abuse Treat Prev Policy. 2025 Jul 7;20(1):28. doi: 10.1186/s13011-025-00657-7.
2
Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time.2012年至2021年美国食品药品监督管理局新型肿瘤治疗药物批准的关键试验中女性、老年人以及少数族裔患者的代表性:亮点试验及随时间的趋势
JCO Oncol Pract. 2025 Jun 10:OP2400563. doi: 10.1200/OP-24-00563.
3
Developing a stakeholder-informed social responsibility model for translational science.为转化科学制定一个由利益相关者提供信息的社会责任模型。
PLoS One. 2025 Jun 9;20(6):e0320956. doi: 10.1371/journal.pone.0320956. eCollection 2025.
4
An Analysis of Institutional Review Board Policies for Enrollment of Adults with Impaired or Uncertain Decision-Making Capacity.针对成年决策能力受损或不确定者入组的机构审查委员会政策分析
J Empir Res Hum Res Ethics. 2025 Jul;20(3):123-130. doi: 10.1177/15562646251338183. Epub 2025 May 8.
5
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groups.分散式临床试验中的多样性:优先纳入代表性不足的群体。
BMC Med Ethics. 2025 Apr 24;26(1):51. doi: 10.1186/s12910-025-01211-7.
6
Advocating for collaboration among key partners to promote diversity in clinical studies amid policy challenges in the United States of America.在美国面临政策挑战的情况下,倡导关键合作伙伴之间开展合作,以促进临床研究的多样性。
Trials. 2025 Apr 2;26(1):117. doi: 10.1186/s13063-025-08820-y.
7
Fitting a square peg in a round hole? A mixed-methods study on research ethics and collaborative health and social care research involving 'vulnerable' groups.方枘圆凿?一项关于研究伦理以及涉及“弱势群体”的健康与社会照护合作研究的混合方法研究。
Health Res Policy Syst. 2025 Apr 1;23(1):40. doi: 10.1186/s12961-025-01290-3.
8
The Importance of Including Underserved Populations in Research.在研究中纳入服务不足人群的重要性。
Pharmaceut Med. 2025 Mar;39(2):59-71. doi: 10.1007/s40290-025-00562-1. Epub 2025 Apr 1.
9
Institutional community engagement leader perspectives on supporting ethical community-engaged research.机构社区参与领导者对支持符合伦理的社区参与研究的看法。
J Clin Transl Sci. 2025 Jan 6;9(1):e27. doi: 10.1017/cts.2024.1165. eCollection 2025.
10
The Functioning of Ethics Committees in Kazakhstan: Results and Recommendations.哈萨克斯坦伦理委员会的运作:结果与建议
Mater Sociomed. 2024;36(3):192-198. doi: 10.5455/msm.2024.36.192-198.

本文引用的文献

1
Integrating Supported Decision-Making into the Clinical Research Process.将支持性决策纳入临床研究过程。
Am J Bioeth. 2021 Nov;21(11):32-35. doi: 10.1080/15265161.2021.1980141.
2
Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.评估临床试验入选标准中英语语言要求的频率:使用 ClinicalTrials.gov 的系统分析。
PLoS Med. 2021 Sep 14;18(9):e1003758. doi: 10.1371/journal.pmed.1003758. eCollection 2021 Sep.
3
Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.mRNA 新冠疫苗在孕妇中的初步安全性研究结果。
N Engl J Med. 2021 Jun 17;384(24):2273-2282. doi: 10.1056/NEJMoa2104983. Epub 2021 Apr 21.
4
Justice, diversity, and research ethics review.公正、多样性与研究伦理审查。
Science. 2021 Mar 19;371(6535):1209-1211. doi: 10.1126/science.abf2170.
5
Should the Decisions of Institutional Review Boards Be Consistent?机构审查委员会的决定应该保持一致吗?
Ethics Hum Res. 2019 Jul;41(4):2-14. doi: 10.1002/eahr.500022.
6
Research 101: A process for developing local guidelines for ethical research in heavily researched communities.研究 101:为深入研究的社区制定伦理研究地方准则的过程。
Harm Reduct J. 2019 Jul 1;16(1):41. doi: 10.1186/s12954-019-0315-5.
7
Enriching the concept of vulnerability in research ethics: An integrative and functional account.丰富研究伦理中脆弱性概念:一种综合与功能的观点。
Bioethics. 2019 Jan;33(1):19-34. doi: 10.1111/bioe.12471. Epub 2018 Aug 23.
8
When will clinical trials finally reflect diversity?临床试验最终何时才能反映出多样性?
Nature. 2018 May;557(7704):157-159. doi: 10.1038/d41586-018-05049-5.
9
Rethinking the Belmont Report?重新思考《贝尔蒙报告》?
Am J Bioeth. 2017 Jul;17(7):15-21. doi: 10.1080/15265161.2017.1329482.
10
Recognizing Risk and Vulnerability in Research Ethics: Imagining the "What Ifs?".认识研究伦理中的风险与脆弱性:设想“如果……会怎样?”
J Empir Res Hum Res Ethics. 2017 Apr;12(2):107-116. doi: 10.1177/1556264617696920. Epub 2017 Mar 14.

IRBs 与保护-纳入困境:寻求平衡。

IRBs and the Protection-Inclusion Dilemma: Finding a Balance.

机构信息

McGill University.

Advarra IRB.

出版信息

Am J Bioeth. 2023 Jun;23(6):75-88. doi: 10.1080/15265161.2022.2063434. Epub 2022 Apr 28.

DOI:10.1080/15265161.2022.2063434
PMID:35482887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9926358/
Abstract

Institutional review boards, tasked with facilitating ethical research, are often pulled in competing directions. In what we call the protection-inclusion dilemma, we acknowledge the tensions IRBs face in aiming to both protect potential research participants from harm and include under-represented populations in research. In this manuscript, we examine the history of protectionism that has dominated research ethics oversight in the United States, as well as two responses to such protectionism: inclusion initiatives and critiques of the term vulnerability. We look at what we know about IRB decision-making in relation to protecting and including "vulnerable" groups in research and examine the lack of regulatory guidance related to this dilemma, which encourages protection over inclusion within IRB practice. Finally, we offer recommendations related to how IRBs might strike a better balance between inclusion and protection in research ethics oversight.

摘要

机构审查委员会的任务是促进伦理研究,但往往会受到相互竞争的方向的影响。在我们所谓的保护-包容困境中,我们承认 IRB 面临的紧张局势,即既要保护潜在的研究参与者免受伤害,又要将代表性不足的人群纳入研究中。在本文中,我们研究了在美国主导研究伦理监督的保护主义历史,以及对这种保护主义的两种回应:包容性倡议和对脆弱性一词的批判。我们研究了我们对 IRB 决策的了解,这些决策与保护和包括“脆弱”群体参与研究有关,并研究了与这一困境相关的缺乏监管指导,这鼓励了 IRB 实践中的保护而不是包容。最后,我们提出了一些建议,涉及 IRB 如何在研究伦理监督中更好地平衡包容和保护。